Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REAGIK-STEMI: Pre-hospital GIK in Acute STEMI
NCT02591927Phase 3Unknown
- Sponsor
- Lausanne University Hospital
- Start
- Feb 2016
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium potassium magnesium calcium and glucose injection, human insulin, potassium phosphates injection in ST elevation myocardial infarction (STEMI), sponsored by Lausanne University Hospital. Status: unknown.
02
Drugs
sodium potassium magnesium calcium and glucose injectionhuman insulinpotassium phosphates injection
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT02591927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02591927.